Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trial
Authors:
Open Access
- 19 September 2012
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (S1) , S14
Abstract
Background: Catheter-associated urinary tract infection (CAUTI) is a common nosocomial device-associated infection. It is now recognized that the high infection rates were caused by the formation of biofilm on the surface of the catheters that decreases the susceptibility to antibiotics and results in anti-microbial resistance. In this study, we performed an in vitro test to explore the mechanism of biofilm formation and subsequently conducted a multi-center clinical trial to investigate the efficacy of CAUTI prevention with the application of JUC, a nanotechnology antimicrobial spray. Methods: Siliconized latex urinary catheters were cut into fragments and sterilized by autoclaving. The sterilized sample fragments were randomly divided into the therapy and control group, whereby they were sprayed with JUC and distilled water respectively and dried before use. The experimental standard strains of Escherichia coli (E. coli) were isolated from the urine samples of patients. At 16 hours and 7 days of incubation, the samples were extracted for confocal laser scanning microscopy. A total of 1,150 patients were accrued in the clinical study. Patients were randomized according to the order of surgical treatment. The odd array of patients was assigned as the therapy group (JUC), and the even array of patients was assigned as the control group (normal saline). Results: After 16 hours of culture, bacterial biofilm formed on the surface of sample fragments from the control group. In the therapy group, no bacterial biofilm formation was observed on the sample fragments. No significant increase in bacterial colony count was observed in the therapy group after 7 days of incubation. On the 7th day of catheterization, urine samples were collected for bacterial culture before extubation. Significant difference was observed in the incidence of bacteriuria between the therapy group and control group (4.52% vs. 13.04%, p < 0.001). Conclusions: In this study, the effectiveness of JUC in preventing CAUTI in a hospital setting was demonstrated in both in vitro and clinical studies.Keywords
This publication has 44 references indexed in Scilit:
- Comparison of Catheter-associated Urinary Tract Infection Rates by Perineal Care Agents in Intensive Care UnitsAsian Nursing Research, 2010
- Blocking of Bacterial Biofilm Formation by a Fish Protein CoatingApplied and Environmental Microbiology, 2008
- Complicated Catheter-Associated Urinary Tract Infections Due toEscherichia coliandProteus mirabilisClinical Microbiology Reviews, 2008
- The EPS Matrix: The “House of Biofilm Cells”Journal of Bacteriology, 2007
- Antibiofilm Activity of GlmU Enzyme Inhibitors against Catheter-Associated UropathogensAntimicrobial Agents and Chemotherapy, 2006
- Biofilm Formation by Moraxella catarrhalis In Vitro: Roles of the UspA1 Adhesin and the Hag HemagglutininInfection and Immunity, 2006
- High-resolution three-dimensional imaging of biofilm development using optical coherence tomographyJournal of Biomedical Optics, 2006
- Indwelling catheter use in home care: elderly, aged 65+, in 11 different countries in EuropeAge and Ageing, 2005
- Catheter-Associated InfectionsArchives of internal medicine (1960), 2004
- Engineering out the Risk of Infection with Urinary CathetersEmerging Infectious Diseases, 2001